Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
The Company will report its official fourth quarter and full year 2024 financial results after the market closes on Tuesday, ...
Inogen reports preliminary Q4 revenue $79M, consensus $73.9M
Inogen . We drove a return to revenue growth, improved profitability and disciplined cost management. Achievements in the quarter included t ...
HME News2d
Inogen expects to exceed full-year guidance
Inogen estimates preliminary, unaudited total revenue for the full year 2024 to be in the range of $334.5 million to $335.5 million, reflecting YOY growth of 6% and exceeding the company’s previous fu ...
News Medical on MSN10d
Inogen receives FDA 510(k) clearance for SIMEOX 200 airway clearance device
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) ...
Pacbiztimes.com16d
Inogen’s newest respiratory device gains FDA clearance
Goleta-based Inogen, a medical technology specializing in the manufacturing of portable oxygen containers, announced Dec. 30 that it had received U.S. Food and Drug Administration clearance for the ...
Morningstar2d
Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
President and Chief Executive Officer of Inogen. “I am confident in our team’s ability to continue delivering on our commitments and providing leading devices for patients with respiratory ...
Business Wire17d
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq ... for patients in the U.S.,” said Kevin Smith, President and Chief Executive Officer. “By tapping into our well-established network of healthcare ...